BiomX (PHGE) Surges as BX211 Cuts Diabetic Wounds by 40%
BiomX Inc. (NASDAQ:PHGE) is a clinical-stage biotechnology company pioneering the development of bacteriophage-based therapies designed to target harmful…
MeiraGTx (MGTX) Reports $3.69M Revenue
MeiraGTx Holdings plc (NASDAQ:MGTX) is a clinical-stage gene therapy company dedicated to developing transformative treatments for patients with…
CytomX (CTMX) Boosts Cash to $158.1M After $100M Raise
CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biotechnology company dedicated to transforming the treatment of cancer through its…
ABVC BioPharma (ABVC) Doubles Assets to $16.2M in Q2 2025
ABVC BioPharma Inc. (NASDAQ:ABVC) is a clinical-stage biopharmaceutical company that operates at the intersection of pharmaceutical innovation and…
Gossamer Bio (GOSS) Wins $10 Price Target
Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…
IO Biotech (IOBT)’s Cancer Vaccine Shows 76% PFS Gain
IO Biotech Inc. (NASDAQ:IOBT) is a clinical-stage biopharmaceutical company pioneering the development of innovative cancer immunotherapies designed to…
Niagen Bioscience (NAGE) Up 503% in 3 Years
Niagen Bioscience, Inc. (NASDAQ:NAGE), formerly known as ChromaDex, is a science-driven company at the forefront of the healthy…
Corvus Pharmaceuticals (CRVS) Net Loss Doubles to $8M in Q2 2025
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to pioneering…
Kestra Medical (KMTS) Surges on 52% Revenue Growth
Kestra Medical Technologies Ltd. (NASDAQ:KMTS) is a fast-rising medical technology company specializing in wearable medical devices and digital…
GlucoTrack (GCTK) Posts $9.6M Cash Reserves
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical device company committed to transforming the way diabetes is managed worldwide.…
Adverum (ADVM) Could Soar 460% With $19.75 Target
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is a clinical-stage biotechnology company pioneering the development of gene therapies for ocular diseases…
Spero Therapeutics (SPRO) Surges After 200% Stock Jump on Phase 3 Success
Spero Therapeutics, Inc. (NASDAQ:SPRO) is a clinical-stage biopharmaceutical company dedicated to developing novel therapies designed to address some…
Tiziana (TLSA) Surges 143% in 2025
Tiziana Life Sciences Ltd. (NASDAQ:TLSA) is a clinical-stage biotechnology company focused on developing breakthrough immunomodulation therapies designed to…
OKYO Pharma (OKYO) Surges on 75% Pain Reduction in Phase 2 Trial
OKYO Pharma Limited (NASDAQ:OKYO) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for ophthalmic conditions, with…
Twist Bioscience (TWST) Eyes 46% Upside with $40 Analyst Target
Twist Bioscience Corporation (NASDAQ:TWST) is a biotechnology company founded in 2013 with a mission to revolutionize the field…
United Therapeutics (UTHR) Tyvaso DPI Sales Hit $315.2M, Up 22% YoY
United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company that has become a standout in the pharmaceutical and life…
Instil Bio (TIL) Skyrockets 180% in One Year
Instil Bio Inc. (NASDAQ:TIL) is a biotechnology company that has steadily built its reputation as an innovator in…
Ideaya (IDYA)’s $530M Servier Deal Could Transform Cancer Care
Ideaya Biosciences Inc. (NASDAQ:IDYA) is a precision medicine oncology company that has positioned itself at the forefront of…